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A B S T R A C T
Purpose: Vagus nerve stimulation (VNS) has been successfully applied to reduce seizure frequency in
numerous patients with epilepsy. However, various side effects, including dyspnea and bradycardia have
been reported, that appear exercise related in some patients. This pilot study aims to obtain insight in the
cardiorespiratory effects of VNS during both rest and exercise.
Methods: Patients with a VNS device who experience side effects during exercise are compared with
patients without side effects. Respiratory and cardiac parameters measured during rest and exercise
include heart rate, breathing frequency and tidal volume.
Results: Sixty-two episodes of VNS in ﬁve patients with and ﬁve patients without side effects were
recorded. In addition, ﬁve control subjects have been measured. During rest, all subjects showed stable
values for the cardiorespiratory parameters. During the ﬁrst minutes of exercise, heart rate, breathing
frequency and tidal volume increased. Thereafter, a steady state was reached again for all subjects.
During VNS episodes, eight out of 10 patients showed a small but consistent decrease in heart rate, along
with an increase in breathing frequency in eight out of nine patients. Tidal volumes decreased during
VNS episodes. These effects, induced by VNS, occurred during both rest and exercise. Magnitude of these
effects varied between patients, but was not necessarily related to the intensity of the experienced side
effects.
Conclusion: This pilot study shows that VNS causes an increase in breathing frequency and a decrease in
tidal volume and heart rate in the majority of patients, during both rest and exercise.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
Seizure
jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
Vagus nerve stimulation (VNS) was ﬁrst introduced in 1988, and
is now an accepted treatment option for patients with refractory
epilepsy, who are not suitable candidates for resective brain surgery
or for whom surgery has failed. VNS consists of intermittent
electrical stimulation of the left cervical vagus nerve, provided by an
implanted pulse generator and a stimulation electrode. The main
purpose of VNS is to reduce seizure frequency, which would ideally
result in a total termination of seizure occurrence. Long term studies
that assessed the efﬁcacy of VNS, concluded that over 50% seizure* Corresponding author at: Department of Neurosurgery, Medisch Spectrum
Twente, PO box 50.000, 7500 KA Enschede, The Netherlands. Tel.: +31 53 4872840.
E-mail address: c.devos@mst.nl (C.C. de Vos).
http://dx.doi.org/10.1016/j.seizure.2015.10.004
1059-1311/ 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights rereduction was accomplished in 20–63% of the patients after
treatment for 6 months to 6 years [1–3].
Beside seizure frequency reduction and other positive effects of
VNS [4], several side effects have been reported. The most commonly
reported side-effects are hoarseness, coughing and dyspnea, with an
incidence reported as high as 66% of patients [5]. Most laryngeal
symptoms have been contributed to vocal cord adduction, caused
by stimulation of the laryngeal branches of the vagus nerve [6].
Respiratory complications by VNS during wake are rarely reported,
while alterations of respiratory patterns during sleep appear to be
more common in both adults [7,8] and children [9,10]. During sleep,
these patients show an increased breathing frequency (BF) and a
decreased tidal volume (TV), as a direct effect of VNS. The exact
mechanism of this effect is not known, but several mechanisms have
been proposed, such as peripheral effects on upper airway muscula-
ture innervated by the vagus nerve or more central mechanisms
inﬂuencing upper airway patency and respiratory effort [7].served.
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have also been reported, during the intra-operative device testing
[11], but there are also reports that mention bradyarrhythmias
during regular treatment, even years after implantation [12,13].
Furthermore, changes in heart rhythm variability have been
observed, although the direction of the variability changes
showed inter-individual differences [13,14]. Cardiac effects of
VNS have been attributed to an ineffective anodal block of the
lower VNS electrode, causing efferent stimulation of the vagus
nerve, which may lead to inhibition of AV conduction tissue,
causing various degrees of AV block, or may slow SA nodal ﬁring,
or even stop it.
In addition, several patients experience hardly any side effects
from VNS during rest, but mention a decrease in physical condition
only during exercise, often reported as breathlessness at those
moments the stimulator is active [4,8]. The cause of this
phenomenon remains unclear; therefore, the aim of this pilot
study is to evaluate the effect of VNS on cardiac and respiratory
functions during rest and exercise, by recording ECG, pulse




Patients with a VNS were recruited via the epilepsy center SEIN
and the neurology department of Medisch Spectrum Twente, The
Netherlands. We included ﬁve epilepsy patients with VNS who
reported shortness of breath and intensiﬁed side effects of the
stimulation during exercise to their treating physician, ﬁve
epilepsy patients with VNS without reported side effects
speciﬁcally during exercise, and ﬁve healthy control subjects, all
of whom had no cardiorespiratory diseases, diabetes or other
disorders affecting the autonomic nerve system. The study
conformed to the Declaration of Helsinki and was approved by
the institutional review board Twente. All subjects gave written
informed consent.
2.2. Measurements
Measurements were performed at the Experimental Center for
Technical Medicine at the University of Twente. Before the start of
the test, patients were asked to ﬁll in a questionnaire regarding
their epilepsy, the VNS induced side effects they experienced and
their exercise habits. The settings of the VNS were read via a
handheld device. A pulse oximeter was placed on the right middle
ﬁnger (Avant 9600, Nonin Medical Inc., MN, USA). Cardiorespira-
tory parameters were acquired synchronously. ECG recordings
were performed with a Viasys ECG monitor and respiratory
parameters were obtained using a Jaeger Oxycon Pro (a mask with
a ﬂow sensor) (both CareFusion, CA, USA). Two bipolar surface
electrodes were placed over the VNS electrode on the left side of
the neck to record episodes of stimulation and on the chest to
record ECG to facilitate heart rate analysis (sample frequency:
2048 Hz).
For the ﬁrst stage of the measurement, the subjects were seated
in a chair for 20 min, reading a magazine. During the second stage
of the measurement, the subjects exercised for 20 min on the
Ergoselect 100 cycle ergometer (ergoline GmbH, Germany), at a
constant level that could be maintained comfortably for the
duration of the test. The subjects with VNS had their standard VNS
settings programmed and had at least three epochs of stimulation
during both the rest and the exercise stage, so that in total at least
60 VNS episodes could be recorded.2.3. Analysis
For every subject with VNS, epochs of 50 s just prior, during and
directly after stimulation were selected, during both rest and
exercise. Respiratory parameters of interest were tidal volume
(TV), breathing frequency (BF) and saturation, and these values
were averaged for each epoch. Obtained ECG data was ﬁltered with
a bandpass Butterworth ﬁlter from 0.5 to 45 Hz (MATLAB, 2011a,
the MathWorks, Inc.). Peak detection was done using the MATLAB
function ﬁndpks. Detected peaks were checked visually and missed
peaks were added or erroneous peaks were deleted manually.
Heart rate, as measured by beats per minute, was calculated and
values were averaged for each epoch. From the same ECG signal,
heart rate variability (HRV) was determined in the time domain, as
the standard deviation of the heart rate in one epoch.
First, the values of patients with VNS were compared to healthy
subjects, to analyze whether the parameters were within the
normal range during rest and exercise. Second, in order to avoid
differences in weighting, average parameters were calculated for
each individual patient before averaging. Third, the average effect
of VNS on the cardiorespiratory parameters for all patients was
analyzed, disregarding subgroup or phase of the test (rest or
exercise), to study the global effect of VNS. Then the speciﬁc test
phase was taken into account, to investigate whether there were
differences between the effect of VNS during rest and exercise.
Last, the subgroups were separated, to investigate whether there
were differences between patients who did and did not report the
side effects during exercise. During both rest and exercise, the
average value of the parameters of the epochs during VNS was
compared with the average value of the parameters during either
the epoch pre or post VNS.
Even though we have a decent number of VNS episodes, the
number of subjects in this pilot study was small. Therefore we did
not test for statistical signiﬁcance, but identiﬁed whether
cardiorespiratory responses to VNS were consistent and reproduc-
ible in patients with and without side effects, and during rest and
exercise.
3. Results
Ten patients with a vagus nerve stimulator and ﬁve healthy
subjects were included. The patients with a VNS were all good
responders to VNS therapy, and were divided in two groups: group
1 consisted of patients who reported side effects during exercise
and group 2 consisted of patients who reported no side effects
during exercise. Average age of all subjects (epilepsy patients and
healthy subjects) was 44 (20–78) years and for the epilepsy
patients the mean time since VNS implantation was 45 (8–132)
months.
An overview of subject characteristics can be found in Table 1.
Subject 1 (group 1) was measured without the mask, so no
respiratory parameters are available. Subject 6 (group 2)
terminated the exercise prematurely, so only one VNS episode
during exercise is available for analysis. Furthermore, epochs
that contained large artifacts hindering proper analysis were
excluded.
3.1. Global effect of exercise
Analysis in both healthy subjects and patients shows constant
values for tidal volume (TV), breathing frequency (BF), heart rate
(HR) and saturation during the 20 min rest period. When exercise
is initiated, TV, BF and HR values increase, until they reach a new
stable value, which is maintained for the remainder of the 20-min
exercise. All values are within normal range and as expected
during low impact exercise, healthy subjects and patients alike.
Table 1










Group 1: with side-effects
1 F 34 23 8 2.00/30/500/60/3 3 2
2 F 41 27 120 2.25/30/250/30/3 6 5
3 F 63 61 9 1.00/20/500/60/5 3 3
4 F 21 21 24 1.75/30/500/60/5 3 2
5 M 67 23 24 1.75/20/250/60/5 3 3
Group 2: without side-effects
6 F 78 72 29 2.00/30/250/60/5 3 1
7 F 52 26 132 1.25/20/130/30/3 4 5
8 M 52 25 10 2.25/30/500/60/5 3 3
9 M 20 8 78 1.75/30/500/60/5 2 3
10 M 44 30 11 2.00/20/500/60/3 3 2
Group 3: controls
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start of the exercise phase, when the new plateau had been
reached.
3.2. Respiratory parameters
Eight out of 10 patients reported hoarseness during VNS, of
which the ﬁve patients in group 1 reported a form of breathless-
ness during VNS. No respiratory data is available for subject 1, so
respiratory parameters are analyzed for 57 VNS episodes in nine
patients. In general, VNS causes a small but reproducible decrease
in tidal volume and an increase in breathing frequency (Table 2).
Regarding the saturation, no clinically signiﬁcant effects of
stimulation or exercise are observed.
During rest, eight out of nine patients show an increase in BF
during VNS. While exercising, six out of nine patients show an
increase in BF during VNS: two patients with and four patients
without reported side effects. The three patients who do not show
the increase in BF during VNS when exercising, show a decrease in
BF, and two of them belong to the group with the reported side
effects (group 1).
In both subgroups and both stages, average TV decreases
during VNS. In rest, eight out of nine patients show a decrease in
TV during VNS, whereas seven out of nine patients show
this during exercise. One patient without reported side effects
(group 2) shows in both stages a small increase in TV during VNS
(1% and 3%).Table 2
Overview of average respiratory values (standard deviation) for each subgroup. Pre, dur
effects, Group 2: without side effects, Group 3: healthy control subjects. SpO2: oxygen
SpO2 [%] (SD) BF [/min] (
Pre During Post Pre 
Rest Group 1 97.3 (1.2) 97.1 (1.4) 97.4 (0.9) 17.7 (4.0) 
Group 2 96.8 (1.0) 96.9 (1.2) 96.8 (1.0) 19.7 (1.2) 
Group 3 97.5 (0.6) 
Exercise Group 1 96.5 (1.7) 96.9 (2.2) 96.9 (1.9) 26.5 (4.0) 
Group 2 97.0 (0.2) 96.7 (0.6) 96.6 (0.6) 22.8 (3.1) 
Group 3 97.4 (1.4) 3.3. Cardiac parameters
With regard to the effects of VNS on cardiac parameters, the
heart rate (HR) has been analyzed. The 50 s epochs before, during
and after VNS that were used for cardiac analysis were ﬁrst visually
inspected, and epochs containing too much noise or artifacts (e.g.
due to movement) to be analyzed were discarded.
For 62 VNS episodes, the HR was calculated. Overall, patients
showed a consistent decrease in HR during VNS, compared with
epochs prior and after VNS (Fig. 1). During rest, nine out of 10
patients show a small decrease in HR during VNS, as compared to
the epoch prior to VNS. Compared to the epoch after VNS, eight out
of 10 patients have a subsequent increase in HR after VNS. During
exercise, six out of 10 patients have a decreased HR during VNS,
compared to the epoch before VNS. These six patients also had a
decrease in HR during rest, and they are evenly distributed over the
two subgroups. Compared to the epoch after VNS, seven out of 10
patients have a subsequent increase in HR after VNS.
Additionally, to check for consistency in HR in between two VNS
episodes, HR values of VNS epochs have also been compared with
epochs not directly preceding or succeeding the stimulation epoch.
Comparison between the stimulation epochs and epochs randomly
in between two subsequent stimulation epochs also shows
decreased HR during VNS in all patients.
The analyzed epochs of 50 s are too short to reliably assess the
heart rate variability within an epoch, so we cannot report on
whether HRV is consistently affected by VNS.ing and post: before, during and after stimulation, respectively. Group 1: with side
 saturation, BF: breathing frequency, TV: tidal volume.
SD) TV [l] (SD)
During Post Pre During Post
19.2 (3.0) 18.7 (3.6) 0.52 (0.25) 0.49 (0.27) 0.48 (0.21)
22.4 (2.9) 20.7 (1.7) 0.40 (0.15) 0.37 (0.13) 0.40 (0.14)
18.8 (2.3) 0.51 (0.07)
25.9 (4.3) 24.6 (4.5) 1.19 (0.48) 1.13 (0.54) 1.14 (0.60)
24.4 (3.2) 22.9 (2.8) 1.16 (0.34) 1.10 (0.32) 1.16 (0.32)
22.4 (1.6) 1.06 (0.19)
Fig. 1. Average heart rate (HR) in beats per minute (bpm), pre, during and post VNS
for both subgroups, during both rest and exercise. Group 1: with side effects, group
2: without side effects. Error bars represent standard deviation.
D.M. Mulders et al. / Seizure 33 (2015) 24–28 274. Discussion
The main purpose of this pilot study was to investigate the effect
of VNS on cardiac and respiratory functions during rest and exercise,
and subsequently, whether there were differences between
patients who reported shortness of breath during exercise and
those who did not. The main ﬁnding of this pilot study is that
individual patients generally show reproducible changes in several
cardiorespiratory parameters during VNS episodes. Overall, this
pilot study shows a decrease in tidal volume and increase in
breathing frequency related to VNS in the majority of the patients
and a consistent decrease in breathing frequency while exercising in
two patients with reported breathlessness during exercising. In all
but one patient heart rate decreases during VNS. Although patients
show cardiorespiratory changes during exercise, these changes are
comparable with or even smaller than the changes during rest. No
speciﬁc VNS induced differences are found between the two groups,
thereby not explaining why some patients with VNS experience
breathlessness during exercise, while others do not.
For this pilot study, patients were divided into two subgroups,
based on whether or not they reported VNS induced shortness of
breath during exercise. However, this separation proved to be
challenging, since side effects in general were experienced in a
gradual manner, or were not perceived as side effects, or did not
counterweight against the beneﬁts of VNS. It is therefore possible
that a patient understated the symptoms and ended up in group 2,
while he or she should have been in group 1, or vice versa.
We believe that the patients who participated in this pilot study
are representative for the (Dutch) healthy VNS patient population
and all patients bike in daily life. By letting them bike at the constant
speed they would bike normally, we have used an exercise which is
perceived equally intensive for all subjects. An interesting difference
though, is that the patients who reported no shortness of breath
during exercise (group 1) might have been in better physical
condition than the patients who did report shortness of breath
(group 2), reﬂected by on average a lower heart rate during rest and
while exercising. There is no cardiorespiratory data available from
these patients prior to VNS implantation, so it is unknown whether
this difference between the two groups was already apparent or
perhaps caused by VNS induced side effects. This will be studied in
our new prospective study.
4.1. Respiratory parameters
The respiratory side effects of VNS, during both wakefulness
and sleep, have been investigated for years. Especially in children,the respiratory pattern is often affected during sleep. Zaaimi et al.
showed increased BF and decreased TV during VNS in 10 children,
sometimes combined with slightly decreased oxygen saturation
[10]. These results are concordant with those of Nagarajan et al.
(2003) [18]. In adults, Banzett et al. found no systematic change in
TV nor BF during wake, but found an increased end-expiratory
volume in patients who received high VNS stimulation intensity
[8]. They attributed this effect to A-ﬁber afferent stimulation.
These ﬁbers carry afferent visceral information, as well as laryngeal
motor stimuli. Binks et al. (2001) [19] showed that the threshold
for A-ﬁber activation is rather low (0.25–1.5 mA) in their adult
subjects. The speciﬁc Ad-ﬁbers carry information from the
pulmonary stretch receptors, which play role in the Hering–
Breuer reﬂex. Increased sensory activity of these pulmonary
stretch lung-afferents results in inhibition of the central inspira-
tory drive and thus inhibition of inspiration and initiation of
expiration. This reﬂex is thought to have a small effect on breathing
rate and depth during rest, while it may inﬂuence rate and depth
when TV exceeds 1 l, as during exercising.
The latter might explain why in this pilot study the majority of
patients showed an increase in BF during VNS, while patient 3
(group 1) and patient 6 (group 2) showed a decrease in BF during
exercise during VNS, as their TV was below 1 l. However, patient 2
also showed a decrease in BF, while her TV exceeded 1 l. Since eight
out of 10 patients reported hoarseness as a side effect of their VNS,
it is likely that their stimulation parameters are high enough to
elicit afferent A-ﬁber activation. That would also explain the
decrease in TV and increase in BF. However, the two patients who
did not explicitly report hoarseness also show the decrease in TV
and increase in BF. They did not experience hoarseness as a
problem.
Furthermore, although there are consistent and reproducible
effects of VNS on respiratory parameters, it is not certain whether
they are clinically relevant and doubtful they could lead to the
feeling of breathlessness during exercise, as there appears to be no
difference in VNS induced respiratory effects between groups 1
and 2.
In this study, respiratory values were obtained every 5 s via a
mask, which is a relatively low sampling rate to study respiratory
differences between stimulation ON and OFF. A more continuous
signal would be preferable, to allow breath-for-breath analysis.
Furthermore, the mask was perceived as uncomfortable by some
subjects, even though it did not impede respiration. It is also
possible that the use of the mask made the subjects more conscious
of their breathing, resulting in more controlled breathing and
thereby inﬂuencing the parameters we studied. Alternatively, a
chest band, capable of measuring variables such as tidal volume
and breathing frequency could be used [8,10].
4.2. Cardiac parameters
Vagal inﬂuence on cardiac function can be an undesirable side
effect in epilepsy patients, but is also explored as a treatment
option for patients with heart failure [15]. Even though
stimulation is applied to the left vagus nerve in epilepsy patients,
in order to diminish the cardiac interference, (intra-operative)
bradycardias and ventricular asystole have been reported [1,11–
13,16]. The majority of patients in the current study showed that
VNS resulted in a small but reproducible decrease in HR. However,
not every patient showed this same response, as one patient in
group 1 showed a small but reproducible increase in HR.
Furthermore, there are two patients who showed both decreases
and some increases in HR during VNS. A previous study by Frei
and Osorio also demonstrated the occurrence of bradycardia as
well as a combination of bradycardia and tachycardia during
stimulation [14].
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reproducible in majority of the patients and clearly related to VNS.
It is however probably too small to play an apparent role in the side
effects experienced during exercise. Nonetheless, the effect could
be of importance, especially as it appears to be present in both
subgroups during both rest and exercise. This effect on heart rate
indicates that most likely not all efferent stimulation of the vagus
nerve is blocked by the VNS anodal block: one of the VNS
electrodes is designed to block efferent stimulation of the vagus
nerve. Failure of this anodal block could result in a decrease in
heart rate [17] and could also be responsible for the hoarseness
many patients report.
Although we found a decrease in TV and an increase in BF and
HR in patients who experienced side effects during exercise, the
same effects on TV and BF were also present in the group who did
not report side effects during exercise. Besides, it turned out that
the effect of VNS on TV and BF was present during both rest and
exercise, and differences were primarily gradual. It is unlikely that
the VNS induced changes in TV, BF and HR during exercise are
exclusively responsible for the feeling of breathlessness in some
patients.
None of the subjects had a history of cardiorespiratory diseases,
diabetes or other disorders that affect the autonomic nerve system
that could have inﬂuenced the results. However, all patients in this
pilot study used medication and although unlikely, it cannot be
ruled out that some of the anticonvulsants or other drugs have
been of inﬂuence on the measured parameters, e.g. heart rate. The
cardiorespiratory parameters obtained in patients were compara-
ble to the parameters that were measured in healthy control
subjects.
Although we analyzed over 60 VNS episodes, only a limited
number of patients participated in this pilot. Several reproducible
cardiorespiratory effects of VNS have been found in all patients, but
the number of patients is too small to differentiate between
patients who report breathlessness during exercise and those who
do not, especially since there seems mainly a gradual difference in
the experienced side effects.
5. Conclusion
We have investigated the effects of VNS on cardiorespiratory
parameters, during both rest and exercise. The breathing frequency
increased, tidal volumes decreased and the heart rate decreased
consistently during VNS episodes in about 80% of our patients.
These effects were present during both rest and exercise, and there
was no clear distinction between the patients who reported VNS
induced side effects during exercise and those who did not.
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